Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyeon Ho Heo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecules and Cells|November 15, 2025
THRAISE: An automated and reproducible web platform for RNA-seq analysisHyeon Ho Heo, Soo-Jong Um
BMC Bioinformatics|October 9, 2025
H<sup>3</sup>NGST: a fully automated, web-based platform for end-to-end ChIP-seq analysisHyeon Ho Heo, Soo-Jong Um
Biochemical and Biophysical Research Communications|May 20, 2025
Loss of Asxl1 disrupts telencephalic midline integrity through dysregulation of SIX3 target genesHyeju Kim, Hyeon Ho Heo, Soo-Jong Um
Journal of Cellular Physiology|February 17, 2026
Epigenetic Silencing of Primary Cilia Genes by PRAME and ETS2 in Melanoma CellsHyeon Ho Heo, HyeSook Youn, Eun-Yi Moon, et al.
Oncogene|September 8, 2025
Tumor antigen PRAME promotes melanoma growth by inactivating p53 through the SIRT1-DBC1 axisYong-Kyu Lee, Hyeon Ho Heo, Ui-Hyun Park, et al.
BMB Reports|June 5, 2024
Tumor antigen PRAME is a potential therapeutic target of p53 activation in melanoma cellsYong-Kyu Lee, Hyeon Ho Heo, Nackhyoung Kim, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecules and Cells|November 15, 2025
THRAISE: An automated and reproducible web platform for RNA-seq analysisHyeon Ho Heo, Soo-Jong Um
BMC Bioinformatics|October 9, 2025
H<sup>3</sup>NGST: a fully automated, web-based platform for end-to-end ChIP-seq analysisHyeon Ho Heo, Soo-Jong Um
Biochemical and Biophysical Research Communications|May 20, 2025
Loss of Asxl1 disrupts telencephalic midline integrity through dysregulation of SIX3 target genesHyeju Kim, Hyeon Ho Heo, Soo-Jong Um
Journal of Cellular Physiology|February 17, 2026
Epigenetic Silencing of Primary Cilia Genes by PRAME and ETS2 in Melanoma CellsHyeon Ho Heo, HyeSook Youn, Eun-Yi Moon, et al.
Oncogene|September 8, 2025
Tumor antigen PRAME promotes melanoma growth by inactivating p53 through the SIRT1-DBC1 axisYong-Kyu Lee, Hyeon Ho Heo, Ui-Hyun Park, et al.
BMB Reports|June 5, 2024
Tumor antigen PRAME is a potential therapeutic target of p53 activation in melanoma cellsYong-Kyu Lee, Hyeon Ho Heo, Nackhyoung Kim, et al.
Pageof 1